Sara A. Hurvitz, Giuseppe Curigliano, Fabrice André, Rachel M. Layman, Robert Wesolowski, Massimo Cristofanilli, Miguel Martín, Alistair E. Ring, Juan Manuel Puig, Martin Eduardo Richardet, Junghoon Shin, Sung-Bae Kim, Liang-Chih Liu, Geronimo Rosselli, Sarah Mutka, Alex Cacovean, Samuel Suzuki, Brian Sullivan, Igor Gorbatchevsky, Barbara Pistilli. "A randomized, open-label, phase 3 study of gedatolisib + fulvestrant ± palbociclib vs standard of care in HR+/HER2−/
                    <i>PIK3CA</i>
                    -mutant (MT) advanced breast cancer (VIKTORIA-1 Study 2).." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.17_suppl.lba1008